The publication will provide a platform to share discoveries and advance knowledge across the field of pediatric and AYA oncology ATLANTA, April 7, 2026 /PRNewswire/ -- The American Cancer Society (ACS) today announced the launch of its fourth medical journal, Pediatric, Adolescent & Young Adult Cancer. This international, multidisciplinary publication will feature peer-reviewed original research and solicited content on the latest advances in cancers affecting children, adolescents, and young a

BLAINVILLE, QC, April 7, 2026 /PRNewswire/ - Duchesnay, a Canadian specialty pharmaceutical company with a long-standing commitment to women's health, member of Duchesnay Pharmaceutical Group (DPG), is proud to announce the Canadian launch of PrRingzaTM, a new contraceptive vaginal system. Continue Reading Ringza (CNW Group/Duchesnay inc.) PrRingzaTM is the result of a collaboration between Duchesnay and the Population Council, an international nonprofit research organization and the product dev

Foundation Honors Rose Ann Weinstein and Narjust Florez, MD, FASCO NEW YORK, April 7, 2026 /PRNewswire/ -- The Lung Cancer Research Foundation's 2026 Gala will spotlight women facing lung cancer with courage and resolve, women we have lost to the disease, and physicians and scientists whose leadership is reshaping outcomes for women everywhere. The gala will be held on Wednesday, September 23, 2026, at Cipriani 25 Broadway in Manhattan. Continue Reading Rose Ann Weinstein, member, LCRF Board of

Join us in Washington or access our virtual newsroom for new nutrition research and policy-relevant findings BETHESDA, Md., April 7, 2026 /PRNewswire/ -- Complimentary press passes are now available for NUTRITION 2026, the annual flagship meeting of the American Society for Nutrition. Join us July 25-28 in National Harbor, Maryland, just outside Washington, D.C., for new, unpublished research on topics shaping national conversations on health, nutrition and policy. From the kitchen table to the

Nikon Contributes to Research on the Effects of Microgravity in Drug Discovery TOKYO, April 7, 2026 /PRNewswire/ -- Nikon Corporation (Nikon) is pleased to announce that the live cell observation system developed by Nikon and its U.S.-based subsidiary Nikon Instruments Inc. (NII) has been selected for "research on the effects of microgravity in life sciences and drug discovery" on board the International Space Station (ISS), supported by the Center for the Advancement of Science in Space (CASIS)

The man fighting cancer with Artemisia annua-infused coffee is now building the one thing AI can't forge: proof of where something actually came from. CAMP HILL, Pa., April 7, 2026 /PRNewswire/ -- Adam Maust, chief executive of ArtemiLife and founder of creative agency Mighty, is announcing the simultaneous launch of three ventures targeting some of the most pressing problems facing businesses and consumers today: the inability to prove true origin in an age of artificial intelligence, the lack

Veteran MedTech commercial leader brings over two decades of operating experience to drive program-building enabled by company's rapid sepsis test SAN FRANCISCO, April 7, 2026 /PRNewswire/ -- Cytovale®, a commercial-stage medical diagnostics company focused on the early detection of sepsis, today announced the appointment of Eric Khairy as Chief Marketing Officer. In this newly created role, Khairy will lead global marketing strategy and execution as the company accelerates adoption of its Intel

MISSISSAUGA, ON, April 7, 2026 /PRNewswire/ - Baylis Medical Technologies Inc. today announced U.S. FDA 510(k) clearance and commercial launch of the PowerWire® 14 Radiofrequency (RF) Guidewire, designed to facilitate the crossing of completely occluded native or stented peripheral vessels 3mm in diameter or greater. The PowerWire® 14 RF Guidewire is the first 0.014" RF-enabled crossing wire, offering physicians a smaller-profile option when navigating challenging occlusions. Building on the est

Company to participate in oral showcase and poster presentation at leading forum for respiratory innovation IRVINE, Calif., April 7, 2026 /PRNewswire/ -- Qnovia, a clinical-stage company focused on advancing new approaches to nicotine cessation, today announced it has been selected to present at the 2026 Respiratory Innovation Summit (RIS), hosted by the American Thoracic Society. The event will take place May 15–16 in Orlando, Florida. Qnovia was selected from a competitive pool of applicants t

Advancing AI-enabled chemical threat detection and dual-use biodefense technologies through initial commercial deployment SACRAMENTO, Calif., April 7, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (NASDAQ: LNAI), an AI-driven drug discovery and biodefense company, today announced that its subsidiary, BioSymetrics, has entered into a revenue-generating, commercial defense-focused collaboration with a specialized biotechnology partner to support the development of an advanced AI-enabled platform for c